Webinar Date

Wednesday, September 20, 2017
 Add to Calendar  Add to Calendar
1:00 PM Eastern 12:00 PM Central
11:00 AM Mountain 10:00 AM Pacific

Options for treating multiple myeloma have expanded significantly, with new drugs and even entirely new therapeutic approaches advancing from clinical trials to doctor's office in recent years. As a result of the expanding treatment landscape, the concepts of minimal residual disease, pros and cons of maintenance therapy, and precision medicine have emerged and are becoming important aspects of myeloma patient care.

To help myeloma patients keep pace with these exciting advancements and become stronger advocates for their own care, the Multiple Myeloma Research Foundation (MMRF) is providing this series of FREE webinars to review and discuss the current state of myeloma care.

Two convenient ways to participate:

  • By phone
  • Online

I would like to register for the following webinar(s):

  Webinar 1 — Minimal Residual Disease
Wednesday, September 20, 2017, 1:00 PM ET
  Webinar 2 — Pros and Cons of Maintenance Therapy
Wednesday, October 4, 2017, 1:00 PM ET
  Webinar 3 — Precision Medicine
Wednesday, November 1, 2017, 1:00 PM ET

If you are unable to register online or do not receive your confirmation email after registering (don't forget to check your Junk email folder), please contact our Registration Desk at 866-872-5840 (international callers please dial 617-502-2061). You can also contact us by email Send Email

There is no fee for participating in this webinar. To register, please complete the required information and click Submit.

*Indicates required information.

Please note, a registration confirmation will be sent to this email address.

By providing your mobile phone number, you agree to receive a text reminder for this activity. Standard text messaging rates may apply.

Please provide the names and email addresses of additional participants who will be joining you on the webinar.

First name Last name Email


As part of our registration process, we ask you to complete the pre-webinar evaluation below:

1. *How much do you agree with the following statements?

I know what minimal residual disease is and why it should be measured.

I understand the concept of precision medicine.

I am knowledgeable about maintenance therapy.

I am comfortable discussing the potential for minimal residual disease testing, maintenance therapy, and precision medicine with my health care team.

2. Please list a question about multiple myeloma (to be addressed by myeloma experts during the webinars)

Please select a program from the above list.

Powered by BeaconLive